2012 Controversies in Neuroscience Session
Wednesday, April 25, 2012
2:00 p.m. – 5:00 p.m.
Moderators: Joseph Jankovic, MD, FAAN and Walter Rocca, MD, MPH
Join 10 experts in their fields as they discuss five of today's most controversial topics in neuroscience. Using the debate format, two speakers will take questions and answers—and challenge each other's knowledge.
Opening remarks Joseph Jankovic, MD, FAAN
2:00 p.m. – 2:05 p.m.
CSF and Alzheimer's Disease Biomarkers
2:05 p.m. – 2:35 p.m.
| 2:05 p.m. – 2:10 p.m. | Side 1: Biomarkers for AD: Ready for Prime Time? Ronald Petersen, MD, PhD |
| 2:10 p.m. – 2:15 p.m. | Side 2: Aβ biomarkers (Aβ42 in CSF and Aβ imaging with PET scanning) should be used clinically. To diagnose persons with mild cognitive impairment at risk for dementia due to Alzheimer's Disease, and for research in cognitively normal persons. Niklas Mattsson, MD, PhD |
| 2:15 p.m. – 2:20 p.m. | Rebuttal Ronald Petersen, MD, PhD |
| 2:20 p.m. – 2:25 p.m. | Rebuttal Niklas Mattsson, MD, PhD |
| 2:25 p.m. – 2:35 p.m. | Open Discussion/Questions |
The Rising Prevalence of Autism
2:35 p.m. – 3:05 p.m.
| 2:35 p.m. – 2:40 p.m. | Side 1: Does the increased prevalence of autism imply a health crisis? (Pro) Lawrence Brown, MD |
| 2:40 p.m. – 2:45 p.m. | Side 2: Does the increased prevalence of autism imply a health crisis? (Con) Max Wiznitzer, MD, FAAN |
| 2:45 p.m. – 2:50 p.m. | Rebuttal Lawrence Brown, MD |
| 2:50 p.m. – 2:55 p.m. | Rebuttal Max Wiznitzer, MD, FAAN |
| 2:55 p.m. – 3:05 p.m. | Open Discussion/Questions |
Diaphragm Pacing for ALS (Pacer Study)
3:05 p.m. – 3:35 p.m.
| 3:05 p.m. – 3:10 p.m. | Side 1: Treatment and interpretation of the findings of this study (Pro) Raymond Onders, MD |
| 3:10 p.m. – 3:15 p.m. | Side 2: Treatment and interpretation of the findings of this study (Con) Catherine Lomen-Hoerth, MD, PhD |
| 3:15 p.m. – 3:20 p.m. | Rebuttal Raymond Onders, MD |
| 3:20 p.m. – 3:25 p.m. | Rebuttal Catherine Lomen-Hoerth, MD, PhD |
| 3:25 p.m. – 3:35 p.m. | Open Discussion/Questions |
Break
3:35 p.m. – 3:50 p.m.
How much adult neurology training does a child neurologist need?
3:50 p.m. – 4:20 p.m.
| 3:50 p.m. – 3:55 p.m. | Side 1: Increasing the length of required child neurology training (and reducing adult neurology training) for child neurologists Donald Gilbert, MD, FAAN |
| 3:55 p.m. – 4:00 p.m. | Side 2: Maintaining the current length of required adult neurology training for child neurologists Douglas Larsen, MD, M.Ed. |
| 4:00 p.m. – 4:05 p.m. | Rebuttal Donald Gilbert, MD, FAAN |
| 4:05 p.m. – 4:10 p.m. | Rebuttal Douglas Larsen, MD, M.Ed. |
| 4:10 p.m. – 4:20 p.m. | Open Discussion/Questions |
Surgery versus Stenting (CREST Trial)
4:20 p.m. – 4:50 p.m.
| 4:20 p.m. – 4:25 p.m. | The Case for Stenting Osama Zaidat, MD, FAAN |
| 4:25 p.m. – 4:30 p.m. | The Case for Endarterectomy James Meschia, MD, FAAN |
| 4:30 p.m. – 4:35 p.m. | Rebuttal Osama Zaidat, MD, FAAN |
| 4:35 p.m. – 4:40 p.m. | Rebuttal James Meschia, MD, FAAN |
| 4:40 p.m. – 4:50 p.m. | Open Discussion/Questions |